{
    "profile_id": "wtvgermeraad",
    "first_name": "Wilfred",
    "last_name": "Germeraad",
    "sub_title": "Chief Scientific Officer at CiMaas",
    "profile_picture": "https://media.licdn.com/dms/image/C4E03AQGz0xd-MJe5cQ/profile-displayphoto-shrink_800_800/0/1517763310858?e=1701302400&v=beta&t=PU71ir3Oee5k4FeE8XxLuhEsUZU4wuaaFmf3IzampTc",
    "background_image": "https://media.licdn.com/dms/image/C4E16AQHJjIeFgQXbDQ/profile-displaybackgroundimage-shrink_350_1400/0/1517763311492?e=1701302400&v=beta&t=4HddOQJPFWsVS0XwDrdSJFZDuRA2N-blMwSv6XY4T0g",
    "profile_type": "personal",
    "entity_urn": "ACoAAAEFXsABcE-RIvmV5KPwiIZG1u9_2ymawoQ",
    "object_urn": 17129152,
    "birth_date": null,
    "summary": "Trained as a (molecular) immunologist, it is my ultimate goal that patients can benefit from fundamental and translational medical science. To this end, doctors, scientists and teachers have to collaborate at the university level. Bringing our research to the patients, we have started CiMaas BV, a company developing and manufacturing Natural Killer cells as treatment for cancer.",
    "location": {
        "country": "Netherlands",
        "short": "Maastricht, Limburg",
        "city": "Maastricht",
        "state": "Limburg",
        "default": "Maastricht, Limburg, Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            }
        ],
        "profile_languages": [
            {
                "name": "Dutch",
                "proficiency": "NATIVE_OR_BILINGUAL"
            },
            {
                "name": "English",
                "proficiency": "FULL_PROFESSIONAL"
            },
            {
                "name": "German",
                "proficiency": "LIMITED_WORKING"
            },
            {
                "name": "Japanese",
                "proficiency": "LIMITED_WORKING"
            }
        ]
    },
    "industry": "Research",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1988
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 1994
                }
            },
            "school": {
                "name": "Kyoto University",
                "logo": "https://media.licdn.com/dms/image/C560BAQF1k5rVwaOJkw/company-logo_400_400/0/1519907057732?e=1703721600&v=beta&t=AQUw5YquitJe5Ve2TJowWf5MLk2nZ8S1vKU6phfBRi0",
                "url": "https://www.linkedin.com/school/%E4%BA%AC%E9%83%BD%E5%A4%A7%E5%AD%A6/"
            },
            "degree_name": "PhD",
            "field_of_study": "Immunology",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1980
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 1987
                }
            },
            "school": {
                "name": "Vrije Universiteit Amsterdam (VU Amsterdam)",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQGFG964atm3Ow/company-logo_400_400/0/1682661887840?e=1703721600&v=beta&t=871s4br2EokXU4GPzYVwsoy3BpQAoKkgU-c2zYvtGmQ",
                "url": "https://www.linkedin.com/school/vrije-universiteit-amsterdam/"
            },
            "degree_name": "MSc",
            "field_of_study": "Medical Biology",
            "grade": null
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [
        {
            "name": "BKO -  Basic Teaching Qualification",
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "authority": "FHML, Maastricht University",
            "url": null,
            "license_number": null,
            "display_source": null,
            "company": null
        },
        {
            "name": "SMBWO Immunology",
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "authority": "SMBWO",
            "url": null,
            "license_number": null,
            "display_source": null,
            "company": null
        }
    ],
    "organizations": [],
    "projects": [
        {
            "title": "Cooperation in higher education and training between EU partners and Japan",
            "date": {
                "start": {
                    "month": 10,
                    "day": null,
                    "year": 2013
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "description": "The consortium consists of 4 European (Maastricht University, Universite catholique de Louvain, University of Lille 1, University of Cologne) and 3 Japanese universities (University of Toho, Tohoku and Kyoto Prefectural University of Medicine) that each offer accredited Master programmes in Biomedicine. he goals of the project is to implement a Double European - Japan Master's Degree program in Biomedicine with a specialization in Neuroscience.",
            "contributors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Wilfred",
                    "last_name": "Germeraad",
                    "name": null,
                    "headline": "Chief Scientific Officer at CiMaas"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Nicole ",
                    "last_name": "Senden",
                    "name": null,
                    "headline": "Maastricht University, Faculty of Health, Medicine and Life Sciences Policy officer/ project manager School for Mental Health and Neuroscience (MHeNs) / Coordinator European Graduate School of Neuroscience (EURON)"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Harry W.M.",
                    "last_name": "Steinbusch",
                    "name": null,
                    "headline": "Prof. Cell. & Translational Neuroscience; EIC J. Chemical Neuroanatomy Elsevier; Co-Chairman IBRO-EC Mentorship program ; Best Neuroscience Scientists 2023: World place 510, NL place 10."
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Pascal Kienlen-Campard",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Michel Salzet and Sigrun Korsching",
                    "headline": null
                }
            ]
        }
    ],
    "publications": [],
    "courses": [],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": 64556963,
                "name": "CiMaas BV",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQHjuG17hwz05Q/company-logo_400_400/0/1680264735717?e=1703721600&v=beta&t=FKNd-VG664_lbAsNfALjTa2J65zKJTEBIesVS3sEmhs",
                "url": "https://www.linkedin.com/company/cimaas/",
                "employees": {
                    "start": 2,
                    "end": 10
                }
            },
            "date": {
                "start": {
                    "month": 3,
                    "day": null,
                    "year": 2015
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Maastricht Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2017
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "CiMaas BV",
                    "description": null,
                    "title": "Chief Operating Officer",
                    "employment_type": null
                },
                {
                    "location": "Maastricht Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 3,
                            "day": null,
                            "year": 2015
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "CiMaas BV",
                    "description": "CiMaas is a start-up biotech company (spin-off from Maastricht University) focused on the development of cellular immunotherapy for cancer patients. The companies\u2019 lead products are natural killer (NK) cells for adoptive transfer that are obtained from healthy donors. Our NK cells have already proven in rodent studies to demonstrate great anti-tumor activity, leading to >80% cure.\n\nDonor derived NK cells will be manufactured by CiMaas in its own GMP facility using a specific bio-reactor allowing production of the required high numbers of these cells needed in patients with cancer in only 12 days.\n\nCiMaas is building up an immune therapy pipeline to develop this technology. This pipeline might partly be based on R&D activities performed at the MUMC+, Maastricht, the Netherlands. Initiatives of other institutes in the field of cell therapy in cancer will also be explored.",
                    "title": "Chief Scientific Officer",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 164802,
                "name": "Maastricht University Medical Center",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQFA1gR1FvG8aQ/company-logo_400_400/0/1588059465102?e=1703721600&v=beta&t=5E9Moi4Han_VxrPz2BT0jDZmVl8Q-Rn0ESe1JTXGjLA",
                "url": "https://www.linkedin.com/school/maastricht-university/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 2003
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Maastricht",
                    "date": {
                        "start": {
                            "month": 7,
                            "day": null,
                            "year": 2011
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Maastricht University",
                    "description": "We aim to develop Immunotherapy. In this work we have various projects. Our first project is targeting of tumor antigens to Dendritic cells for tumour vaccine development. We have identified cocktails for better DC maturation that improve CD8+ T cell generation as well as attraction and activation of NK cells. Clinically we work on hematopoietic stem cell transplantations for patients with hematopoietic malignancies. These patients often suffer from opportunistic infections and many die because of it. Therefore we study de novo generation of T cells in a so-called \"artificial thymus\" for adoptive transfer. We can generate T cell precursors in vitro that mature in the thymus after injection into immunodeficient mice. Finally we would like to transfer the idea of HSC transplantation to solid tumors, like breast cancer. In various mice models, we could cure 50-80% of them depending on the model. We have identified that NK cells clear the tumour.\n\nFurther activities\nEducation:\nOverall Coordinator Clinical Investigator (KO) of A-KO master 2010-2016\nMember Curriculum Committee A-KO master 2010-2016\nMaster coordinator Biomedical Sciences 2013-2019\n   Double Degree program with Tohoku University and  Kyoto Prefectural University of Medicine, Japan\nMember management team Biomedical Sciences 2013-2019\nCoordinator/Member of various teaching course coordination groups\nTeaching graduate and undergraduate students\n\nManagement:\nTrainer/Coordinator \u201cSMBWO Immunologist\u201d certification in Maastricht \nDepartmental Biosafety Expert\nInstitutional FACS Unit supervision\n\nMembership:\nDutch Society of Immunology \n- Lunteren Symposium Committee\n- 50th anniversary Lustrum committee\n- 8-UMC citytour committee (chairman)\n- Program committee member\nDutch Society for Hematology\n- Program committee member",
                    "title": "Associate Professor",
                    "employment_type": null
                },
                {
                    "location": "Maastricht Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 7,
                            "day": null,
                            "year": 2009
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2011
                        }
                    },
                    "company": "Maastricht University",
                    "description": "Developing immunotherapy for cancer",
                    "title": "Assistant Professor",
                    "employment_type": null
                },
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 2003
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2009
                        }
                    },
                    "company": "Maastricht University",
                    "description": "Developing immunotherapy for cancer.",
                    "title": "Senior Scientist",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 15417,
                "name": "Crucell",
                "logo": "https://media.licdn.com/dms/image/C560BAQG4IkT-TRWuLQ/company-logo_400_400/0/1519855939934?e=1703721600&v=beta&t=h0i3XHAYpcyrKzEJIycoxd8QsikHxIVfBh2NG4UYxfs",
                "url": "https://www.linkedin.com/company/crucell/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 1998
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2002
                }
            },
            "profile_positions": [
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 1998
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2002
                        }
                    },
                    "company": "Crucell",
                    "description": "Targeting Dendritic cells for tumor vaccine development\nMolecular aspects of human dendritic cell differentiation",
                    "title": "Teamleader",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 165790,
                "name": "RSM Erasmus University",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQGxI95CurHtdA/company-logo_400_400/0/1657183585379?e=1703721600&v=beta&t=aCXWkOkWMdJMHXNL9Vddw4uRJ-HP4LalJ3pi7y5Ok9A",
                "url": "https://www.linkedin.com/school/rotterdam-school-of-management-erasmus-university/",
                "employees": {
                    "start": 501,
                    "end": 1000
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 1996
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 1997
                }
            },
            "profile_positions": [
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 1996
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 1997
                        }
                    },
                    "company": "Rotterdam School of Management, Erasmus University",
                    "description": "The role of the thymic stroma in T cell differentiation",
                    "title": "Postdoc",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 8517,
                "name": "UMC Utrecht",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQG50uAl6TiV2g/company-logo_400_400/0/1638562574508?e=1703721600&v=beta&t=QbCFXysjMpGxtCXdDSvyoDAU_IocWkFz-iVcJQ1M47c",
                "url": "https://www.linkedin.com/company/umcutrecht/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 5,
                    "day": null,
                    "year": 1996
                },
                "end": {
                    "month": 9,
                    "day": null,
                    "year": 1996
                }
            },
            "profile_positions": [
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": 5,
                            "day": null,
                            "year": 1996
                        },
                        "end": {
                            "month": 9,
                            "day": null,
                            "year": 1996
                        }
                    },
                    "company": "UMC Utrecht",
                    "description": "With phage antibody display technology we generated monoclonal antibodies against thymic epithelial cells",
                    "title": "guest Postdoc",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 2476,
                "name": "Childrens Hospital Los Angeles",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQHh4DSAHecNkQ/company-logo_400_400/0/1519855918197?e=1703721600&v=beta&t=ohlWCShxQCZ9nRD38OxMOQllHOG-iKQZz8laubI1q6o",
                "url": "https://www.linkedin.com/company/childrensla/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 1994
                },
                "end": {
                    "month": 3,
                    "day": null,
                    "year": 1996
                }
            },
            "profile_positions": [
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 1994
                        },
                        "end": {
                            "month": 3,
                            "day": null,
                            "year": 1996
                        }
                    },
                    "company": "Children's Hospital Los Angeles (CHLA)",
                    "description": "Transgenic and knock-out animal models for Philadelphia chromosome positive leukemia",
                    "title": "Postdoc",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "Immunology",
        "Cell",
        "FACS",
        "Flow Cytometry",
        "Animal Models",
        "Lifesciences",
        "In Vitro",
        "Molecular Biology",
        "Immunohistochemistry",
        "Grant Writing",
        "Biochemistry",
        "Monoclonal Antibodies",
        "Oncology",
        "Clinical Trials",
        "Stem Cells",
        "Life Sciences",
        "Cell Biology",
        "Rna Isolation"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}